PCS
BLCM

Personal CFO Solutions’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Personal CFO Solutions’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,450
Closed -$32K – 389
2019
Q4 		$32K Buy
+2,450
New +$22.6K 0.01% 341

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Personal CFO Solutions's BLCM Position: Q1 2020 in Review

Personal CFO Solutions sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2020, closing a stake of 2,450 shares — an estimated $32K sold.

Personal CFO Solutions first reported a position in BLCM in Q4 2019 and held it in 1 quarter. The position peaked at $32K in Q4 2019. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2020.

  • Personal CFO Solutions reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Personal CFO Solutions sold 2,450 Bellicum Pharmaceuticals, Inc. shares in Q1 2020, an estimated $32K.
  • Personal CFO Solutions first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2019 and held it in 1 quarter.
  • Personal CFO Solutions's Bellicum Pharmaceuticals, Inc. position peaked at $32K in Q4 2019.
  • 29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2020.

Based on Personal CFO Solutions's 13F filing for Q1 2020, filed 30 Apr 2020.